ã°ã©ã¯ãœã»ã¹ãã¹ã¯ã©ã€ã³ç€Ÿã¯ãåäŒç€Ÿãšãšãã«ãè±åœãç±³åœãããã³åœéçã«å»è¬åãã¯ã¯ãã³ãäžè¬çšå»è¬åãå¥åº·é¢é£æ¶è²»è
補åã®éçºãçºèŠãéçºã補é ãããã³ããŒã±ãã£ã³ã°ãè¡ã£ãŠããŸããå瀟ã¯ãå»è¬åãå»è¬åç ç©¶éçºãã¯ã¯ãã³ãããã³æ¶è²»è
ãã«ã¹ã±ã¢ã® 4 ã€ã®ã»ã°ã¡ã³ãã§äºæ¥ãå±éããŠããŸããå瀟ã¯ãåŒåžåšãHIVãå
ç«ççãè
«çåŠãæãŠã€ã«ã¹ãäžæ¢ç¥çµç³»ãå¿è¡ç®¡ããã³æ³å°¿çæ®åšã代è¬ãæèãããã³ç®èç§ãªã©ã®æ²»çé åã®å»è¬åãå«ãå»è¬åãæäŸããŠããŸãããŸããå¥åº·ãå£è
è¡çãæ é€ãããã³ç®èã®å¥åº·ã®åéã§æ¶è²»è
ãã«ã¹ã±ã¢è£œåãæäŸããŠããŸããå瀟ã¯ãç¹éŒ»è¬ãé å€ãã·ãããããããŒããã¬ã ãçµç®ããããã«ãã¬ãããä¹³å
çšã·ãããæ»Žãæ¶²äœå
å¡«æžæ¿æ¶²ãã¯ã€ãããžã§ã«ãçºæ³¡å€ãæ¯ç£šãç²ãæ¯ãã©ã·ãããŠã¹ãŠã©ãã·ã¥ã矩æ¯å®å®å€ããã³æŽæµå€ã屿çšã¯ãªãŒã ããã³éè¬çšãããããªããã¯ãªãŒã ãã°ãããœãããã¥ãŒã®åœ¢ã§æ¶è²»è
åããã«ã¹ã±ã¢è£œåãæäŸããŠããŸããå瀟ã¯ã23andMeãLyell ImmunopharmaãInc.ãNovartisãSanofi SAãSurface OncologyãProgentec DiagnosticsãInc.ãAlectorãInc.ãCureVac AG ãšååå¥çŽãçµãã§ããã»ããIDEAYA BiosciencesãInc. ããã³ Vir BiotechnologyãInc. ãšæŠç¥çããŒãããŒã·ãããçµãã§ããŸããGlaxoSmithKline plc 㯠1715 幎ã«èšç«ãããæ¬ç€Ÿã¯è±åœãã¬ã³ããã©ãŒãã«ãããŸãã